Enclosed herewith Financial Results for the year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Auro Laboratories Ltd reported strong financial performance for FY 2025-26. Revenue from operations grew 58.5% to Rs 3,074 lakhs from Rs 1,940 lakhs in the previous year. Profit after tax nearly doubled to Rs 353 lakhs from Rs 184 lakhs, representing a 92% increase. EPS improved to Rs 5.67 from Rs 2.95. Finance costs more than tripled to Rs 425 lakhs due to increased borrowing for capex. The company completed major capital expenditure with PPE increasing from Rs 2,106 lakhs to Rs 7,518 lakhs. Operating cash flow turned positive at Rs 211 lakhs after being negative in the prior year. Auditors issued an unmodified (clean) opinion on the financial statements.
Strong revenue and profit growth is positive for shareholders. However, the tripling of finance costs and increased debt levels warrant monitoring. The clean audit opinion provides assurance on financial reporting quality.